{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T17:40:04Z","timestamp":1755970804453,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,23]]},"DOI":"10.7759\/cureus.90826","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T16:59:52Z","timestamp":1755968392000},"source":"Crossref","is-referenced-by-count":0,"title":["Trammels Entailed in Convalescent Plasmapheresis During the COVID-19 Pandemic: Emphasizing the Anti-SARS-CoV-2 IgG Antibody Level in Repeat Voluntary Convalescent Plasma Donors"],"prefix":"10.7759","author":[{"given":"Susmita","family":"Behera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan  M","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijayalaxmi","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihar R","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabindra K","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i1.9397","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"Cucinotta D","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020, 91:157-60. 10.23750\/abm.v91i1.9397","journal-title":"Acta Biomed"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen L","year":"2020","unstructured":"Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 2020, 20:398-400. 10.1016\/S1473-3099(20)30141-9","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4940","article-title":"Convalescent plasma to treat COVID-19: possibilities and challenges","volume":"323","author":"Roback JD","year":"2020","unstructured":"Roback JD, Guarner J. Convalescent plasma to treat COVID-19: possibilities and challenges. JAMA. 2020, 323:1561-2. 10.1001\/jama.2020.4940","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2450\/2015.0131-15","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano G","year":"2016","unstructured":"Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Liumbruno GM, Grazzini G. Convalescent plasma: new evidence for an old therapeutic tool?. Blood Transfus. 2016, 14:152-7. 10.2450\/2015.0131-15","journal-title":"Blood Transfus"},{"key":"ref5","article-title":"COVID-19 convalescent plasma: from donation to treatment - a systematic review & single center experience","volume":"118","author":"Fabricius MM","year":"2021","unstructured":"Fabricius MM, Dandachi D. COVID-19 convalescent plasma: from donation to treatment - a systematic review & single center experience. Mo Med. 2021, 118:74-80.","journal-title":"Mo Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: possible mechanisms of action","volume":"19","author":"Rojas M","year":"2020","unstructured":"Rojas M, Rodr\u00edguez Y, Monsalve DM, et al.. Convalescent plasma in Covid-19: possible mechanisms of action. Autoimmun Rev. 2020, 19:102554. 10.1016\/j.autrev.2020.102554","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102875","article-title":"Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study","volume":"59","author":"Abolghasemi H","year":"2020","unstructured":"Abolghasemi H, Eshghi P, Cheraghali AM, et al.. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfus Apher Sci. 2020, 59:102875. 10.1016\/j.transci.2020.102875","journal-title":"Transfus Apher Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.06.028","article-title":"Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients","volume":"95","author":"Joyner MJ","year":"2020","unstructured":"Joyner MJ, Bruno KA, Klassen SA, et al.. Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin Proc. 2020, 95:1888-97. 10.1016\/j.mayocp.2020.06.028","journal-title":"Mayo Clin Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa228","article-title":"Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019","volume":"222","author":"Zeng QL","year":"2020","unstructured":"Zeng QL, Yu ZJ, Gou JJ, et al.. Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019. J Infect Dis. 2020, 222:38-43. 10.1093\/infdis\/jiaa228","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2196\/25500","article-title":"Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis","volume":"7","author":"Peng HT","year":"2021","unstructured":"Peng HT, Rhind SG, Beckett A. Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis. JMIR Public Health Surveill. 2021, 7:e25500. 10.2196\/25500","journal-title":"JMIR Public Health Surveill"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12926","article-title":"Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?","volume":"115","author":"Tiberghien P","year":"2020","unstructured":"Tiberghien P, de Lamballerie X, Morel P, Gallian P, Lacombe K, Yazdanpanah Y. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?. Vox Sang. 2020, 115:488-94. 10.1111\/vox.12926","journal-title":"Vox Sang"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2016.06.016","article-title":"Ethics and blood donation: a marriage of convenience","volume":"45","author":"Tissot JD","year":"2016","unstructured":"Tissot JD, Garraud O. Ethics and blood donation: a marriage of convenience. Presse Med. 2016, 45:e247-52. 10.1016\/j.lpm.2016.06.016","journal-title":"Presse Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa803","article-title":"Temporal analysis of serial donations reveals decrease in neutralizing capacity and justifies revised qualifying criteria for coronavirus disease 2019 convalescent plasma","volume":"223","author":"Girardin RC","year":"2021","unstructured":"Girardin RC, Dupuis AP, Payne AF, Sullivan TJ, Strauss D, Parker MM, McDonough KA. Temporal analysis of serial donations reveals decrease in neutralizing capacity and justifies revised qualifying criteria for coronavirus disease 2019 convalescent plasma. J Infect Dis. 2021, 223:743-51. 10.1093\/infdis\/jiaa803","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13185","article-title":"Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial","volume":"289","author":"Madariaga ML","year":"2021","unstructured":"Madariaga ML, Guthmiller JJ, Schrantz S, et al.. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021, 289:559-73. 10.1111\/joim.13185","journal-title":"J Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2021.02.003","article-title":"Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these","volume":"28","author":"Mahapatra S","year":"2021","unstructured":"Mahapatra S, Pati S. Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these. Transfus Clin Biol. 2021, 28:175-9. 10.1016\/j.tracli.2021.02.003","journal-title":"Transfus Clin Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.14.20065771","article-title":"A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease","author":"Huang AT","year":"2020","unstructured":"Huang AT, Garcia-Carreras B, Hitchings MD, et al.. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. medRxiv. 2020, 10.1101\/2020.04.14.20065771","journal-title":"medRxiv"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.10.051","article-title":"Quick Covid-19 healers sustain anti-SARS-CoV-2 antibody production","volume":"183","author":"Chen Y","year":"2020","unstructured":"Chen Y, Zuiani A, Fischinger S, et al.. Quick Covid-19 healers sustain anti-SARS-CoV-2 antibody production. Cell. 2020, 183:1496-507. 10.1016\/j.cell.2020.10.051","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24230-5","article-title":"Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan","volume":"12","author":"Li C","year":"2021","unstructured":"Li C, Yu D, Wu X, et al.. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nat Commun. 2021, 12:4144. 10.1038\/s41467-021-24230-5","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2021.05.005","article-title":"Relationship between blood type and outcomes following COVID-19 infection","volume":"34","author":"Kim Y","year":"2021","unstructured":"Kim Y, Latz CA, DeCarlo CS, et al.. Relationship between blood type and outcomes following COVID-19 infection. Semin Vasc Surg. 2021, 34:125-31. 10.1053\/j.semvascsurg.2021.05.005","journal-title":"Semin Vasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382458-trammels-entailed-in-convalescent-plasmapheresis-during-the-covid-19-pandemic-emphasizing-the-anti-sars-cov-2-igg-antibody-level-in-repeat-voluntary-convalescent-plasma-donors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T16:59:54Z","timestamp":1755968394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382458-trammels-entailed-in-convalescent-plasmapheresis-during-the-covid-19-pandemic-emphasizing-the-anti-sars-cov-2-igg-antibody-level-in-repeat-voluntary-convalescent-plasma-donors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.90826","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,23]]}}}